How many stocks are there of Quotient?
The current number of stocks of Quotient is 2.55 M undefined.
Quotient Stocks 2024
Quotient Stocks
2.55 M
Ticker
QTNT
ISIN
JE00BLG2ZQ72
WKN
A11598
In 2024, Quotient had 2.55 M outstanding stocks, a 0% change from the 2.55 M stocks in the previous year.
The Quotient Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2026e | 2.55 |
| 2025e | 2.55 |
| 2024e | 2.55 |
| 2023e | 2.55 |
| 2022 | 2.55 |
| 2021 | 2.29 |
| 2020 | 1.79 |
| 2019 | 1.37 |
| 2018 | 1.02 |
| 2017 | 0.7 |
| 2016 | 19.56 |
| 2015 | 14.77 |
| 2014 | 14.38 |
| 2013 | 14.38 |
| 2012 | 14.38 |
| 2011 | 14.38 |
Quotient shares outstanding JE00BLG2ZQ72 · A11598
The number of shares was Quotient in 2023 — This indicates how many shares 2.548 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Quotient earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Quotient's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Quotient’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Quotient's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2011 | 14.38 M Aktien |
| 2012 | 14.38 M Aktien |
| 2013 | 14.38 M Aktien |
| 2014 | 14.38 M Aktien |
| 2015 | 14.77 M Aktien |
| 2016 | 19.56 M Aktien |
| 2017 | 703,640 Aktien |
| 2018 | 1.02 M Aktien |
| 2019 | 1.37 M Aktien |
| 2020 | 1.79 M Aktien |
| 2021 | 2.29 M Aktien |
| 2022 | 2.55 M Aktien |
| 2023e | 2.55 M Aktien |
| 2024e | 2.55 M Aktien |
| 2025e | 2.55 M Aktien |
| 2026e | 2.55 M Aktien |
Quotient Aktienanalyse
What does Quotient do?
Quotient Ltd is a biopharmaceutical company headquartered in Eysins, Switzerland. The company was founded in 2007 with the aim of developing innovative technologies in the field of Personalized Medicine. This means that medications and therapies are specifically tailored to the individual needs of patients. Thanks to state-of-the-art production processes, products can be produced quickly and safely. Quotient Ltd has a unique business model based on transfusion technology. This technology allows the company to produce medications quickly and accurately. The different components of the medications are separated and then combined in the required dosage. This means that the medications can be precisely dosed and the risks of side effects minimized. A key focus of Quotient Ltd is the development of therapeutics. Personalized medicine and the fast and safe production of medications are at the center of this area. The transfusion technology enables medications to be produced quickly and flexibly, which is particularly important for rare diseases and personalized therapies. Another important area is the development of diagnostics. These enable diseases to be diagnosed quickly and safely. Based on this diagnosis, suitable therapies are then developed. Quotient Ltd also relies on transfusion technology for this, which enables fast, reliable, and flexible production of diagnostics. In addition to its developed technology and know-how, Quotient Ltd also has its own production facility. Here, all products are produced to the highest standards. The production facility covers an area of approximately 6,000 square meters. The modern facility is equipped with the latest technologies and meets the highest quality standards. Quotient Ltd offers a variety of products, with a special focus on personalized medicine and the fast and safe production of medications and diagnostics. One example is the PDA diagnostic system, which was developed for the fast and accurate diagnosis of autoimmune diseases. The MosaiQ system is another important product that enables fast and reliable production of medications. The success story of Quotient Ltd is closely linked to the development of transfusion technology. The company has succeeded in developing a technology that allows for the fast and safe production of personalized medicine. This technology has made Quotient Ltd a leading company in the field of personalized medicine worldwide. Today, Quotient Ltd employs over 700 people who are constantly working on the further development of personalized medicine and transfusion technology. Quotient ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Quotient's Shares Outstanding
Quotient's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Quotient’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Quotient’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Quotient’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Quotient stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Quotient are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Quotient evolved in recent years?
The number of shares of Quotient has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Quotient as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Quotient?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Quotient pay?
Over the past 12 months, Quotient paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Quotient is expected to pay a dividend of 0 USD.
What is the dividend yield of Quotient?
The current dividend yield of Quotient is .
When does Quotient pay dividends?
Quotient pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Quotient?
Quotient paid dividends every year for the past 0 years.
What is the dividend of Quotient?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Quotient located?
Quotient is assigned to the 'Health' sector.
Wann musste ich die Aktien von Quotient kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Quotient from 9/14/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/14/2024.
When did Quotient pay the last dividend?
The last dividend was paid out on 9/14/2024.
What was the dividend of Quotient in the year 2023?
In the year 2023, Quotient distributed 0 USD as dividends.
In which currency does Quotient pay out the dividend?
The dividends of Quotient are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Quotient
Our stock analysis for Quotient Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quotient Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
